AbbVie | Capital Ordinaire



Ordinary Share Capital Changement Date
AbbVie USD 18M 0 2024-12
Abbott USD 25.12B 28M 2025-03
ALKERMES USD 165.05M 163.25M 2025-06
Amgen USD 538M 33.04B 2025-06
AstraZeneca USD 1.55B 1.16B 2025-06
Biogen USD 146.6M 146.5M 2025-06
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Eisai JPY 282.12M 44.7B 2025-06
Eli Lilly USD 946.83M 354.23M 2025-06
Gilead Sciences USD 1.24B 3M 2025-06
GlaxoSmithKline GBP 4.15B 2.8B 2025-06
J&J USD 3.12B 0 2025-03
Medtronic USD 128K 128K 2025-04
Merck USD 1.79B 0 2025-03
Neurocrine Biosciences USD 99M 0 2025-06
Novartis USD 793M 0 2024-12
Pacira USD 44.9M 44.85M 2025-06
Perrigo USD 137.6M 6.56B 2025-06
Pfizer USD 5.68B 5.2B 2025-06
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Roche Holding CHF 107M 0 2024-06
Sanofi 1.22B 36.5M 2025-06
UCB EUR 584M 0 2024-12
Ultragenyx Pharmaceutical USD 96.35M 2.45M 2025-06
United Therapeutics USD 45.22M 44.42M 2025-06
Vertex Pharmaceuticals USD 256.3M 253.7M 2025-06
Zoetis USD 443.95M 438.95M 2025-06


AbbVie Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.